| My Account | Subscribe | Contact Us | Help |
Our Sixth Annual Product Reference Guide contains 11 charts with over 300 products. You’ll find the guide is useful all year long. Use it whenever you’re contemplating a change in your diabetes care products.
The must-have resource for physicians, educators and medical professionals who focus on the treatment of diabetes.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
Related Medications Threads on Diabetes Health Forums
Cinnamon: Should It Be Taken as a Diabetes Medication?
The Chinese mentioned cinnamon in their written work more than 4,000 years ago. The ancient Egyptians used cinnamon in their embalming process, and the Roman writer/philosopher Pliny the Elder wrote in the first century AD that cinnamon was worth 15 times more than silver of the same weight.
21 comments - Dec 25, 2008 -
Making the Medicare Prescription Drug Program Work For Boomers and Their Parents
No one knows better than people with diabetes how expensive prescription drugs are. A recent DH article reported that the annual cost for drugs to treat type 2 diabetes nearly doubled between 2001 and 2007, skyrocketing from $6.7 billion to $12.5 billion six years later.
3 comments - Nov 17, 2008 -
An Old Diabetes Drug Standby Might Lower Heart Risks
Metformin, the tried-and-true diabetes drug that is prescribed to many type 2s when they are first diagnosed, may decrease the risk of death from cardiovascular disease. That's the conclusion of a meta-analysis by researchers at the Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland.
0 comments - Nov 3, 2008 -
The Cost of Progress
The annual cost for drugs to treat type 2 diabetes nearly doubled between 2001 and 20, skyrocketing from $6.7 billion in 2001 to $12.5 billion six years later, according to researchers from Stanford University and the University of Chicago.
0 comments - Nov 3, 2008 -
Sanofi-Aventis Study Sees Significant A1c Reductions with Lantus and Apidra Compared to Pre-mixed Insulin for Type 2s
At the recent 44th annual meeting of the European Association for the Study of Diabetes (EASD), sanofi-aventis announced a study demonstrating that a basal-bolus insulin regimen with Lantus® once daily (basal insulin) and rapid-acting Apidra® (insulin glulisine [rDNA origin] injection) at mealtime (bolus insulin) resulted in significant A1c reductions from baseline as compared to pre-mixed insulin in people with type 2 diabetes.
4 comments - Sep 29, 2008 -
Is This the ACCORD Study’s Silver Lining?
Several months ago researchers suspended work on the landmark ACCORD (Action to Control Cardiovascular Risk in Diabetes) study, which tracked 10,251 type 2s, some of them undergoing very tight control of their blood sugar levels.
0 comments - Aug 14, 2008 -
Following Dr. Bernstein on Holiday
At the beginning of 2007, we began studying guidebooks and making reservations for a long-anticipated trip to New Zealand and Australia. With limited funds and so much we wanted to do, we decided our budget would go farther if we stayed at hostels. At the same time, we were concerned about Al’s rising blood sugar scores. After visiting relatives during Christmas and celebrating the New Year, Al’s morning scores were as high as 154 mg/dl.
3 comments - Aug 14, 2008 -
Byetta Breaks the Piggy Bank
San Diego-based Amylin Pharmaceuticals, Inc., posted a second-quarter loss of $64.8 million, or 47 cents per share. This compares to a 2007 second-quarter loss of 45 million, or 34 cents a share.
1 comment - Jul 31, 2008 -
New Consumer Guide in Spanish Helps Type 2s Compare Diabetes Drugs
A new Spanish language consumer guide to type 2 diabetes, called “Pastillas para la diabetes tipo 2,” has been released by the Agency for Healthcare Research and Quality (AHRQ). The guide provides information on how to control type 2 and includes comparisons of oral medications. AHRQ data show that nearly one in eight Hispanics takes a prescription drug for diabetes.
0 comments - Jul 24, 2008 -
Metformin May Aid in Weight Loss for Obese Pre-Diabetic Teen Girls
Metformin, combined with dietary changes and exercise, seems to help obese pre-diabetic adolescents, especially girls, lose weight, says a report in the June 2008 Journal of Pediatrics.
7 comments - Jul 10, 2008 -